FDA Approved: PLAVIX — Supplemental Application (Sanofi-Aventis U.S. LLC)

View source ↗

Summary

FDA approved a supplemental application for PLAVIX (clopidogrel) submitted by Sanofi-Aventis U.S. LLC. The approval concerns changes to the product’s labeling a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome
• Myocardial Infarction
• Peripheral Arterial Disease
• Stroke

Drugs mentioned

• Plavix (clopidogrel)

Snippet

SUPPL AP for PLAVIX (CLOPIDOGREL)